Signe Friesland

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.6K citations · Full text

Medicine, Pathology, Head And Neck Cancer +5

Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy

Pia Baumann, Jan Nyman, Berit Wennberg et al. · Journal of Clinical Oncology · 2009 · 838 citations · Full text

A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction

Fredrik Klevebro, Gabriella Alexandersson von Döbeln, N. Wang et al. · Annals of Oncology · 2016 · 389 citations

Gastro-oesophageal Junction, Randomized Clinical Trial, Surgical Oncology +10

Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival

Hanna Mellin, Signe Friesland, Rolf Lewensohn et al. · International Journal of Cancer · 2000 · 373 citations

Pathology, Treatment Resistance, Viral Oncology +21

SPACE – A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC

Jan Nyman, Andreas Hallqvist, Jo-Åsmund Lund et al. · Radiotherapy and Oncology · 2016 · 339 citations · Full text

Inoperable Stage, Radiation Medicine, Radiation Therapy +8